[
Webinar
|
August 16, 2022
]

ICH and Pharma 4.0: The Implications for Brazil

ICH and Pharma 4.0: The Implications for Brazil

A 60-minute cross-industry panel of experts will explore how the recently adopted International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guidelines will impact key stakeholders in the manufacturing of pharmaceutical products in Brazil.

Regulatory professionals, pharmaceutical executives, academic researchers, and other interested parties will gain an understanding of how the ICH Guidelines, Pharma 4.0 and Quality by Design principles intersect in the advancement of pharmaceutical manufacturing.

Speakers

Watch the webinar

502676ed-00bc-4361-b20a-b9e2640851f8
HubSpot form (set the "Hubspot form ID" property) renders here on the published site.
6 photos
[
Webinar
 I
]

Every Day Counts: Raising the Bar in Gene Therapy with Science & Structure

Tech Transfer
[
Webinar
 I
]

Weaving the Digital Threads for Life Sciences

Digital CMC
[
Webinar
 I
]

Accelerating QbD: Perspectives on Product Risk Assessments for Advanced Biologics

[
News & Announcements
 I
October 13, 2026
]

QbDVision Joins Industry Leaders to Launch the Digital CMC Consortium

QbDVision
[
Blog Post
 I
October 20, 2026
]

Scalable AI for CMC: How To Measure Whether It Can Be Trusted

Artificial Intelligence
[
Customer Story
 I
November 8, 2023
]

From Paper to 3X Faster Technology Transfers

Tech Transfer
[
General Manager
]

Gustavo Mendes Lima Santos

[
Client Service Specialist
]

Sana Ahmed

[
President
]

Mario Brenga Gianpetro

[
Associate Professor in Pharmaceutics
]

Walkiria Schlindwein

[
Owner
]

Line Lundberg

[
President & CEO
]

Yash Sabharwal

Yash Sabharwal is an accomplished inventor, entrepreneur, and executive specializing in the funding and growth of early-stage technology companies focused on life science applications. He has started 3 companies and successfully exited his last two, bringing a wealth of strategic and tactical experience to the team.